Kymera
safety and from sad and mad dose portion of phase trial in healthy volunteers jared chief medical officer | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
19 of 105
Related slides by other companies
Avantor
Results
October 2023
investor day a new york stock exchange and on investor relations register at wear | Avantor
Boundless Bio
IPO
March 2024
the in phase potentiate trial targeting induced replication stress via inhibition | Boundless Bio
Ocuphire Pharma
Results
October 2022
zeta phase trial in diabetic | Ocuphire Pharma
Ocuphire Pharma
Results
October 2022
zeta trial demographics and masked safety data | Ocuphire Pharma
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io